He is currently working in the European Medical Department of Biogen and coordinates the efforts at the Innovative Medicines Initiative (IMI) and real world data in Alzheimer’s disease. He has over 16 years of relevant clinical research experience, in different positions in clinical practice, industrial early clinical development/experimental medicine and medical affairs in Neuroscience (Alzheimer's disease and multiple sclerosis) and Infectious Diseases (neglected tropical diseases) at headquarters of GlaxoSmithKline, Otsuka and Lundbeck.